Found: 14
Select item for more details and to access through your institution.
T cell subtype profiling measures exhaustion and predicts anti-PD-1 response.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-05474-7
- By:
- Publication type:
- Article
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
- By:
- Publication type:
- Article
Phase II study of dacarbazine given with modern prophylactic anti-emetics and growth factor support to patients with metastatic, resistant soft tissue, and bone sarcoma.
- Published in:
- Rare Tumors, 2021, p. 1, doi. 10.1177/20363613211052498
- By:
- Publication type:
- Article
Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 4, p. 481, doi. 10.1002/cam4.382
- By:
- Publication type:
- Article
A prospective trial comparing FDG- PET/ CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck.
- Published in:
- Cancer Medicine, 2014, v. 3, n. 6, p. 1493, doi. 10.1002/cam4.294
- By:
- Publication type:
- Article
Metastasis occurring eleven years after diagnosis of human papilloma virus-related oropharyngeal squamous cell carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Case Study
Hearing Outcomes in a Deintensification Trial of Adjuvant Therapy for HPV‐Related Oropharyngeal Squamous Cell Carcinoma.
- Published in:
- Otolaryngology-Head & Neck Surgery, 2023, v. 168, n. 5, p. 1089, doi. 10.1002/ohn.182
- By:
- Publication type:
- Article
Dynamic host immune response in virus-associated cancers.
- Published in:
- Communications Biology, 2019, v. 2, n. 1, p. N.PAG, doi. 10.1038/s42003-019-0352-3
- By:
- Publication type:
- Article
A phase 2 trial of induction nab-paclitaxel and cetuximab given with cisplatin and 5-fluorouracil followed by concurrent cisplatin and radiation for locally advanced squamous cell carcinoma of the head and neck.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 4, p. 766, doi. 10.1002/cncr.27741
- By:
- Publication type:
- Article
Cisplatin versus Cetuximab Given Concurrently with Definitive Radiation Therapy for Locally Advanced Head and Neck Squamous Cell Carcinoma.
- Published in:
- Oncology, 2013, v. 85, n. 5, p. 290, doi. 10.1159/000355194
- By:
- Publication type:
- Article
nab-Paclitaxel and cisplatin followed by cisplatin and radiation (Arm 1) and nab-paclitaxel followed by cetuximab and radiation (Arm 2) for locally advanced head and neck squamous-cell carcinoma: a multicenter, non-randomized phase 2 trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Prospective assessment of the clinical benefit of a tailored cancer gene set built on a next-generation sequencing platform in patients with recurrent or metastatic head and neck cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical benefit of nanoparticle albumin- bound-paclitaxel in recurrent/metastatic head and neck squamous cell carcinoma resistant to cremophor-based paclitaxel or docetaxel.
- Published in:
- Medical Oncology, 2017, v. 34, n. 2, p. 1, doi. 10.1007/s12032-017-0884-7
- By:
- Publication type:
- Article